Subscribe

Anixa Biosciences, Inc. (ANIX)

USD3.61 +0.42 (+13.17%)
US NASDAQ Healthcare Biotechnology
Address 3150 Almaden Expressway 95118
San Jose, CA, US
CEO Amit Kumar
Website anixa.com
IPO 1983-10-07
CIK 715446 ISIN US03528H1095

Explore sections of this company profile

Description

Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T-cell (CER-T) technology, an innovative adaptation of CAR-T, specifically for ovarian cancer treatment. The company is also engaged in the discovery and development of antiviral drug candidates to combat COVID-19, focusing on the inhibition of specific viral protein functions. On the vaccine front, Anixa's initiatives include a vaccine designed to target triple-negative breast cancer and a distinct preventative vaccine aimed at ovarian cancer. Beyond specific therapies and vaccines, Anixa also has immuno-therapy drugs for various cancers in its development portfolio. A key collaboration exists with MolGenie GmbH for the discovery and development of its COVID-19 antiviral candidates. Tracing its origins back to an incorporation in 1982, the company initially operated as ITUS Corporation before adopting the name Anixa Biosciences, Inc. in October 2018. It is headquartered in San Jose, California.

News Sentiment (7d)
Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD3.61 +0.42 (+13.17%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
162.7K
Beta
0.60
Float Shares
31.72M
Free Float %
94.6%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.29% -10.31% -21.67% -21.14% -54.19% -24.68% -32.66% -30.27% -45.73% -29.22% -86.89%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (6 ratings, all time) Buy
Price Targets & DCF
Current price
3.61
Low 3.50 -3.0%
Consensus 5.83 +61.5%
Median 4.00 +10.8%
High 10.00 +177.0%
DCF (Unlevered) 0.03 -99.2%
DCF (Levered) 0.03 -99.1%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 3 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year
All Time 3
5.83
+61.5%
Quality scores
Altman Z-Score
3.32
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
  • EPS growth Biotechnology: +29.7%
    +12.8% Q2'26: +19.2% (vs Q2'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
  • EBIT margin Biotechnology: +0.0%
  • ROIC Biotechnology: -16.1%
  • Share dilution Biotechnology: -3.4%
    +1.7% Q2'26: +4.3% (vs Q2'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -0.02× Q2'26: -0.02× (vs Q2'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.60) × ERP
WACC = 100% × Ke + 0% × Kd (4.3%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 0.03 Current price: 3.61
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Oct 2015
actual
Oct 2016
actual
Oct 2017
actual
Oct 2018
actual
Oct 2019
actual
Oct 2021
actual
Oct 2023
actual
Oct 2024
actual
Oct 2025
actual
Oct 2026
1 EPS Ana.
Oct 2027
2 Rev. Ana.
1 EPS Ana.
Oct 2028
2 EPS Ana.
Oct 2029
1 Rev. Ana.
1 EPS Ana.
Oct 2030
1 Rev. Ana.
1 EPS Ana.
Revenue
9.26M
est: 45.00M (-79.4%)
300.0K
est: 45.00M (-99.3%)
362.5K
est: 60.00M (-99.4%)
1.11M
est: 1.11M (0.0%)
250.0K
est: 250.0K (+0.0%)
512.0K
est: 500.0K (+2.4%)
210.0K
est: 210.0K (+0.0%)
est: 150.00M (-100.0%)
est: 120.00M (-100.0%)
— – —
-100.0% YoY
34.00M
34.00M – 34.00M
— – —
-100.0% YoY
22.60M
22.60M – 22.60M
82.10M
82.10M – 82.10M
+263.3% YoY
EBITDA
-601.8K
est: -50.0K (-1,102.6%)
-4.14M
est: -50.0K (-8,168.4%)
-4.14M
est: -66.7K (-6,104.5%)
-13.90M
est: -1.2K (-1,123,534.0%)
-11.00M
est: -278.00 (-3,958,514.0%)
-13.08M
est: -556.00 (-2,352,647.3%)
-10.97M
est: 42.0K (-26,207.8%)
-12.66M
est: 30.00M (-142.2%)
-11.70M
est: 24.00M (-148.8%)
— – —
-100.0% YoY
6.80M
6.80M – 6.80M
— – —
-100.0% YoY
4.52M
4.52M – 4.52M
16.42M
16.42M – 16.42M
+263.3% YoY
EBIT
-927.1K
est: -50.2K (-1,747.0%)
-4.50M
est: -50.2K (-8,857.5%)
-4.51M
est: -66.9K (-6,636.2%)
-14.24M
est: -1.2K (-1,147,610.2%)
-11.47M
est: -278.00 (-4,126,250.7%)
-13.14M
est: -557.00 (-2,358,248.3%)
-11.01M
est: 42.0K (-26,317.3%)
-12.70M
est: 30.00M (-142.3%)
-11.70M
est: 24.00M (-148.8%)
— – —
-100.0% YoY
6.80M
6.80M – 6.80M
— – —
-100.0% YoY
4.52M
4.52M – 4.52M
16.42M
16.42M – 16.42M
+263.3% YoY
Net Income
-1.38M
est: 71.77M (-101.9%)
-5.02M
est: 71.77M (-107.0%)
-5.01M
est: 111.64M (-104.5%)
-14.00M
est: -21.05M (+33.5%)
-11.65M
est: -22.65M (+48.6%)
-12.95M
est: -13.08M (+1.0%)
-9.81M
est: -12.00M (+18.2%)
-12.55M
est: -12.82M (+2.1%)
-10.93M
est: -11.54M (+5.4%)
-10.87M
-10.87M – -10.87M
+5.8% YoY
-11.36M
-11.36M – -11.36M
-4.5% YoY
-12.17M
-12.98M – -11.36M
-7.1% YoY
-13.96M
-13.96M – -13.96M
-14.7% YoY
52.90M
52.90M – 52.90M
+479.1% YoY
SGA
5.51M
est: 411.86M (-98.7%)
2.71M
est: 411.86M (-99.3%)
4.41M
est: 549.14M (-99.2%)
6.91M
est: 10.19M (-32.1%)
5.66M
est: 2.29M (+147.5%)
7.07M
est: 4.58M (+54.6%)
6.29M
est: 1.96M (+220.2%)
7.44M
est: 1.40B (-99.5%)
6.63M
est: 1.12B (-99.4%)
— – —
-100.0% YoY
318.05M
318.05M – 318.05M
— – —
-100.0% YoY
211.40M
211.40M – 211.40M
768.01M
768.01M – 768.01M
+263.3% YoY
EPS
-0.14
est: 2.25 (-106.2%)
-0.57
est: 2.25 (-125.3%)
-0.41
est: 3.50 (-111.7%)
-0.79
est: -0.66 (-19.7%)
-0.61
est: -0.71 (+14.1%)
-0.45
est: -0.41 (-9.8%)
-0.32
est: -0.37 (+13.5%)
-0.39
est: -0.40 (+1.3%)
-0.34
est: -0.36 (+4.4%)
-0.34
-0.34 – -0.34
+5.8% YoY
-0.35
-0.35 – -0.35
-4.5% YoY
-0.38
-0.40 – -0.35
-7.1% YoY
-0.43
-0.43 – -0.43
-14.7% YoY
1.63
1.63 – 1.63
+479.1% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-06-10 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-06-09 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-06-08 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-06-05 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-06-04 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-06-03 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-06-02 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-06-01 C 2/5 3/5 1/5 1/5 4/5 1/5 1/5
2026-05-28 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-27 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-26 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-22 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-21 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-20 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-19 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-18 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-15 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-14 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-13 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-12 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-11 C 2/5 2/5 1/5 1/5 4/5 1/5 1/5
2026-05-08 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-07 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-06 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-05 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-04 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-05-01 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-30 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-29 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-28 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-27 C- 1/5 2/5 1/5 1/5 3/5 1/5 1/5
2026-04-24 C- 1/5 2/5 1/5 1/5 2/5 1/5 1/5
2026-04-23 C- 1/5 2/5 1/5 1/5 2/5 1/5 1/5
2026-04-22 C- 1/5 2/5 1/5 1/5 2/5 1/5 1/5
2026-04-21 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-20 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-17 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5
2026-04-16 C- 1/5 3/5 1/5 1/5 2/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-6.88M
OE per share TTM
-0.21
Owner's Yield
-8.71%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
135.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
63
Total invested
13.18M
Insider transactions (90d)
0
Beneficial owners (>5%)
12
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Overseas Limited 20.00M 13.60% 20.00M 20.00M CO Islands 2010-05-17
2 Denis Krusos 11.97M 6.80% IN Citizenship or Place of Organization 2011-02-18
3 Fidelity National Financial, Inc. 3.90M 6.60% 842.8K 842.8K CO United States of America 2017-01-03
4 Michael Catelani 1.76M 5.25% 1.76M 1.76M IN United States of America 2024-05-03
5 (ENTITIES ONLY) 1.45M 5.40% 1.45M 1.45M IN States of America 2021-02-05
6 AVG GP, LLC 987.6K 6.53% 987.6K 987.6K OO United States 2017-09-13
7 AVG Holdings, LP 987.6K 6.53% 987.6K 987.6K PN United States 2017-09-13
8 AVG Ventures GP, LLC 987.6K 6.53% 987.6K 987.6K OO United States 2017-09-13
9 AVG Ventures, LP 987.6K 6.53% 987.6K 987.6K PN United States 2017-09-13
10 Meetrix Communications, Inc. 987.6K 6.53% 987.6K 987.6K CO United States 2017-09-13
11 Starfighter Trust 987.6K 6.53% 987.6K 987.6K OO United States 2017-09-13
12 Bruce P. Eames 942.6K 5.68% 942.6K 942.6K IN Delaware 2018-01-30

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
63
-8 vs prev Q
New positions
11
Closed positions
19
Increased
27
Reduced
10
Put/Call ratio
0.00
Calls held
70.9K
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 VANGUARD GROUP INC 1.46M +37.2K (+2.6%) 4.55M -139.9K (-3.0%) 4.50% +0.118 pp 0.00% +0.000 pp USD4.21 -25.9% 29 qtrs
2 LAIRD NORTON TRUST COMPANY, LLC 588.0K -9.2K (-1.5%) 1.83M -136.2K (-6.9%) 1.81% -0.027 pp 0.04% -0.301 pp USD3.66 -14.8% 9 qtrs
3 D.A. DAVIDSON & CO. 539.3K -75.0K (-12.2%) 1.68M -344.6K (-17.0%) 1.66% -0.230 pp 0.01% -0.003 pp USD2.22 +40.5% 7 qtrs
4 UBS GROUP AG 459.1K -15.4K (-3.2%) 1.43M -133.5K (-8.5%) 1.41% -0.047 pp 0.00% +0.000 pp USD3.46 -9.8% 29 qtrs
5 GEODE CAPITAL MANAGEMENT, LLC 350.9K +7.3K (+2.1%) 1.10M -39.2K (-3.5%) 1.08% +0.023 pp 0.00% +0.000 pp USD3.95 -21.0% 29 qtrs
6 MISSION WEALTH MANAGEMENT, LP 206.9K -149.3K (-41.9%) 645.5K -529.8K (-45.1%) 0.64% -0.459 pp 0.01% -0.011 pp USD3.27 -4.6% 10 qtrs
7 BLACKROCK, INC. 164.0K +3.0K (+1.8%) 511.6K -19.7K (-3.7%) 0.51% +0.010 pp 0.00% +0.000 pp USD3.05 +2.3% 6 qtrs
8 STATE STREET CORP 159.0K +38.5K (+32.0%) 496.2K +98.6K (+24.8%) 0.49% +0.119 pp 0.00% +0.000 pp USD3.87 -19.4% 19 qtrs
9 683 CAPITAL MANAGEMENT, LLC 113.6K +113.6K (+100.0%) 354.5K +354.5K (+100.0%) 0.35% +0.350 pp 0.02% +0.015 pp USD3.12 +0.0% 1 qtrs NEW
10 EXODUSPOINT CAPITAL MANAGEMENT, LP 93.9K +93.9K (+100.0%) 293.1K +293.1K (+100.0%) 0.29% +0.289 pp 0.00% +0.002 pp USD3.12 +0.0% 1 qtrs NEW
11 LPL FINANCIAL LLC 89.6K +2.6K (+3.0%) 279.6K -7.5K (-2.6%) 0.28% +0.008 pp 0.00% +0.000 pp USD3.00 +4.0% 15 qtrs
12 GSA CAPITAL PARTNERS LLP 82.1K +221.0 (+0.3%) 256.0K -14.0K (-5.2%) 0.25% +0.001 pp 0.02% -0.001 pp USD2.89 +8.0% 4 qtrs
13 QUBE RESEARCH & TECHNOLOGIES LTD 59.5K +59.5K (+100.0%) 185.7K +185.7K (+100.0%) 0.18% +0.183 pp 0.00% +0.000 pp USD3.12 +0.0% 1 qtrs NEW
14 BANK OF NEW YORK MELLON CORP 58.3K +— (+0.0%) 181.8K -10.5K (-5.5%) 0.18% +0.000 pp 0.00% +0.000 pp USD4.31 -27.6% 29 qtrs
15 NORTHERN TRUST CORP 55.8K -1.2K (-2.1%) 174.0K -14.0K (-7.4%) 0.17% -0.004 pp 0.00% +0.000 pp USD3.55 -12.1% 29 qtrs
16 RENAISSANCE TECHNOLOGIES LLC 53.9K +11.1K (+26.0%) 168.1K +27.0K (+19.1%) 0.17% +0.034 pp 0.00% +0.000 pp USD3.11 +0.3% 19 qtrs
17 VIRTU FINANCIAL LLC 51.8K +51.8K (+100.0%) 161.0K +161.0K (+100.0%) 0.16% +0.160 pp 0.01% +0.006 pp USD3.12 +0.0% 1 qtrs NEW
18 CORECAP ADVISORS, LLC 48.0K +1.2K (+2.7%) 149.9K -4.5K (-2.9%) 0.15% +0.004 pp 0.01% 0.000 pp USD3.28 -4.9% 8 qtrs
19 MORGAN STANLEY 46.9K +35.2K (+301.6%) 146.2K +107.7K (+279.7%) 0.14% +0.109 pp 0.00% +0.000 pp USD3.20 -2.5% 29 qtrs
20 WESTSIDE INVESTMENT MANAGEMENT, INC. 44.0K +9.0K (+25.7%) 137.3K +21.8K (+18.9%) 0.14% +0.028 pp 0.02% +0.004 pp USD3.18 -1.9% 11 qtrs
21 ACADIAN ASSET MANAGEMENT LLC 44.3K +23.5K (+113.2%) 136.0K +70.0K (+106.1%) 0.14% +0.073 pp 0.00% +0.000 pp USD3.20 -2.5% 2 qtrs
22 HIGHTOWER ADVISORS, LLC 41.2K +— (+0.0%) 128.4K -7.4K (-5.5%) 0.13% +0.000 pp 0.00% +0.000 pp USD3.47 -10.1% 9 qtrs
23 MARSHALL WACE, LLP 40.6K -22.2K (-35.3%) 126.5K -80.4K (-38.9%) 0.13% -0.068 pp 0.00% 0.000 pp USD3.30 -5.5% 3 qtrs
24 CI PRIVATE WEALTH, LLC 37.4K +— (+0.0%) 116.7K -6.7K (-5.5%) 0.12% +0.000 pp 0.00% +0.000 pp USD4.08 -23.5% 13 qtrs
25 GEMMER ASSET MANAGEMENT LLC 35.0K +— (+0.0%) 109.2K -6.3K (-5.5%) 0.11% +0.000 pp 0.01% -0.001 pp USD3.06 +2.0% 15 qtrs
26 POINT72 ASSET MANAGEMENT, L.P. 31.1K +31.1K (+100.0%) 96.9K +96.9K (+100.0%) 0.10% +0.096 pp 0.00% +0.000 pp USD3.12 +0.0% 1 qtrs NEW
27 OMERS ADMINISTRATION CORP 30.5K +30.5K (+100.0%) 95.2K +95.2K (+100.0%) 0.09% +0.094 pp 0.00% +0.001 pp USD3.12 +0.0% 1 qtrs NEW
28 CITADEL ADVISORS LLC 29.7K -66.3K (-69.1%) 92.6K -224.2K (-70.8%) 0.09% -0.204 pp 0.00% +0.000 pp USD3.30 -5.5% 21 qtrs
29 CIBC PRIVATE WEALTH GROUP, LLC 27.9K +12.3K (+78.6%) 86.9K +35.5K (+68.9%) 0.09% +0.038 pp 0.00% +0.000 pp USD3.22 -3.1% 3 qtrs
30 SQUAREPOINT OPS LLC 26.7K +26.7K (+100.0%) 83.2K +83.2K (+100.0%) 0.08% +0.082 pp 0.00% +0.000 pp USD3.12 +0.0% 1 qtrs NEW
31 GRAHAM CAPITAL MANAGEMENT, L.P. 26.1K +26.1K (+100.0%) 81.4K +81.4K (+100.0%) 0.08% +0.080 pp 0.00% +0.002 pp USD3.12 +0.0% 1 qtrs NEW
32 KESTRA ADVISORY SERVICES, LLC 26.0K +2.0K (+8.3%) 81.1K +1.9K (+2.4%) 0.08% +0.006 pp 0.00% +0.000 pp USD2.78 +12.2% 5 qtrs
33 NATIONS FINANCIAL GROUP INC, /IA/ /ADV 22.5K +— (+0.0%) 70.2K -4.1K (-5.5%) 0.07% +0.000 pp 0.00% -0.001 pp USD3.41 -8.5% 13 qtrs
34 SUSQUEHANNA INTERNATIONAL GROUP, LLP 20.2K +20.2K (+100.0%) 63.0K +63.0K (+100.0%) 0.06% +0.062 pp 0.00% +0.000 pp USD3.12 +0.0% 1 qtrs NEW
35 LIGHTHOUSE INVESTMENT PARTNERS, LLC 17.0K +17.0K (+100.0%) 53.0K +53.0K (+100.0%) 0.05% +0.052 pp 0.00% +0.002 pp USD3.12 +0.0% 1 qtrs NEW
36 KEYBANK NATIONAL ASSOCIATION/OH 15.8K +300.0 (+1.9%) 49.3K -1.9K (-3.6%) 0.05% +0.001 pp 0.00% +0.000 pp USD2.75 +13.5% 16 qtrs
37 ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC 15.6K +— (+0.0%) 48.8K -2.8K (-5.5%) 0.05% +0.000 pp 0.00% 0.000 pp USD2.22 +40.5% 7 qtrs
38 DAKOTA WEALTH MANAGEMENT 15.0K +— (+0.0%) 46.8K -2.7K (-5.5%) 0.05% +0.000 pp 0.00% 0.000 pp USD3.27 -4.6% 10 qtrs
39 PENSIONMARK FINANCIAL GROUP, LLC 14.6K +— (+0.0%) 45.6K -2.6K (-5.5%) 0.05% +0.000 pp 0.00% 0.000 pp USD3.30 -5.5% 2 qtrs
40 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 12.8K +— (+0.0%) 39.9K -2.3K (-5.5%) 0.04% +0.000 pp 0.00% +0.000 pp USD3.06 +2.0% 15 qtrs
41 NEWEDGE WEALTH, LLC 12.5K +— (+0.0%) 39.0K -11.9K (-23.3%) 0.04% +0.000 pp 0.00% 0.000 pp USD3.30 -5.5% 3 qtrs
42 MILLENNIUM MANAGEMENT LLC 12.2K +12.2K (+100.0%) 38.0K +38.0K (+100.0%) 0.04% +0.038 pp 0.00% +0.000 pp USD3.12 +0.0% 5 qtrs
43 SIMPLICITY WEALTH,LLC 12.0K -2.0K (-14.1%) 37.4K -8.7K (-18.8%) 0.04% -0.006 pp 0.00% 0.000 pp USD3.35 -6.9% 8 qtrs
44 WELLS FARGO & COMPANY/MN 12.0K +1.5K (+14.3%) 37.4K +2.8K (+8.1%) 0.04% +0.005 pp 0.00% +0.000 pp USD2.64 +18.2% 29 qtrs
45 CONCORDE ASSET MANAGEMENT, LLC 12.0K -2.0K (-14.1%) 37.4K -8.2K (-17.9%) 0.04% -0.006 pp 0.02% -0.004 pp USD3.30 -5.5% 2 qtrs
46 BENJAMIN EDWARDS INC 11.2K +— (+0.0%) 34.9K -2.0K (-5.5%) 0.03% +0.000 pp 0.00% +0.000 pp USD3.30 -5.5% 3 qtrs
47 CETERA INVESTMENT ADVISERS 11.1K +11.1K (+100.0%) 34.7K +34.7K (+100.0%) 0.03% +0.034 pp 0.00% +0.000 pp USD3.12 +0.0% 1 qtrs NEW
48 NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 10.5K +— (+0.0%) 32.8K -1.9K (-5.5%) 0.03% +0.000 pp 0.00% +0.000 pp USD3.28 -4.9% 4 qtrs
49 PRIVATE ADVISOR GROUP, LLC 10.2K -3.5K (-25.6%) 31.9K -13.5K (-29.7%) 0.03% -0.011 pp 0.00% 0.000 pp USD2.93 +6.5% 4 qtrs
50 STEPHEN J. GARRY & ASSOCIATES, LLC 10.1K +— (+0.0%) 31.5K -1.8K (-5.5%) 0.03% +0.000 pp 0.02% -0.002 pp USD3.88 -19.6% 9 qtrs
51 STALEY CAPITAL ADVISERS INC 10.0K +— (+0.0%) 31.2K -1.8K (-5.5%) 0.03% +0.000 pp 0.00% 0.000 pp USD3.35 -6.9% 8 qtrs
52 BNP PARIBAS ARBITRAGE, SNC 9.1K +9.1K (+100.0%) 28.5K +28.5K (+100.0%) 0.03% +0.028 pp 0.00% +0.000 pp USD3.12 +0.0% 1 qtrs NEW
53 CANADA PENSION PLAN INVESTMENT BOARD 7.5K +7.5K (+100.0%) 23.4K +23.4K (+100.0%) 0.02% +0.023 pp 0.00% +0.000 pp USD3.12 +0.0% 1 qtrs NEW
54 BANK OF AMERICA CORP /DE/ 5.6K -208.4K (-97.4%) 17.4K -688.7K (-97.5%) 0.02% -0.642 pp 0.00% +0.000 pp USD2.94 +6.1% 18 qtrs
55 SIMPLEX TRADING, LLC 5.0K -3.2K (-39.3%) 15.5K -11.5K (-42.6%) 0.02% -0.010 pp 0.00% +0.000 pp USD3.30 -5.5% 2 qtrs
56 JONES FINANCIAL COMPANIES LLLP 3.8K +1.8K (+88.1%) 12.0K +5.0K (+72.6%) 0.01% +0.006 pp 0.00% +0.000 pp USD3.22 -3.1% 2 qtrs
57 PNC FINANCIAL SERVICES GROUP, INC. 3.0K +— (+0.0%) 9.5K -547.0 (-5.5%) 0.01% +0.000 pp 0.00% +0.000 pp USD3.27 -4.6% 10 qtrs
58 MAI CAPITAL MANAGEMENT 2.7K +— (+0.0%) 8.4K -486.0 (-5.5%) 0.01% +0.000 pp 0.00% +0.000 pp USD2.32 +34.5% 5 qtrs
59 NBT BANK N A /NY 2.0K +— (+0.0%) 6.2K -360.0 (-5.5%) 0.01% +0.000 pp 0.00% +0.000 pp USD3.30 -5.5% 3 qtrs
60 ANCORA ADVISORS, LLC 1.5K +— (+0.0%) 4.7K -274.0 (-5.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD3.04 +2.6% 17 qtrs
61 ROYAL BANK OF CANADA 1.4K +426.0 (+42.6%) 4.0K +1.0K (+33.3%) 0.00% +0.001 pp 0.00% +0.000 pp USD3.24 -3.7% 23 qtrs
62 STEPHENS CONSULTING, LLC 1.0K +— (+0.0%) 3.1K -180.0 (-5.5%) 0.00% +0.000 pp 0.00% 0.000 pp USD2.32 +34.5% 5 qtrs
63 PARKSIDE FINANCIAL BANK & TRUST 602.00 +— (+0.0%) 1.9K -108.0 (-5.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD3.30 -5.5% 3 qtrs
64 FEDERATION DES CAISSES DESJARDINS DU QUEBEC 600.00 +— (+0.0%) 1.9K -120.0 (-6.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.86 +9.1% 4 qtrs
65 LARSON FINANCIAL GROUP LLC 500.00 +— (+0.0%) 1.6K -90.0 (-5.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.75 +13.5% 16 qtrs
66 IFP ADVISORS, INC 500.00 +— (+0.0%) 1.6K -90.0 (-5.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.86 +9.1% 4 qtrs
67 NEWEDGE ADVISORS, LLC 495.00 +— (+0.0%) 1.5K -90.0 (-5.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD3.30 -5.5% 3 qtrs
68 US BANCORP \DE\ 400.00 +— (+0.0%) 1.2K -72.0 (-5.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.75 +13.5% 17 qtrs
69 SBI SECURITIES CO., LTD. 223.00 -9.0 (-3.9%) 696.00 -70.0 (-9.1%) 0.00% +0.000 pp 0.00% +0.000 pp USD2.32 +34.5% 5 qtrs
70 ADVISOR GROUP HOLDINGS, INC. 50.00 +— (+0.0%) 156.00 +7.0 (+4.7%) 0.00% +0.000 pp 0.00% +0.000 pp USD3.38 -7.7% 21 qtrs
71 PARK CIRCLE CO -500.0 (-100.0%) -1.7K (-100.0%) 0.00% -0.002 pp 0.00% -0.001 pp USD 10 qtrs SOLD
72 GROUP ONE TRADING, L.P. -4.8K (-100.0%) -15.9K (-100.0%) 0.00% -0.015 pp 0.00% +0.000 pp USD 6 qtrs SOLD
73 PRINCIPAL SECURITIES, INC. -1.0K (-100.0%) -3.3K (-100.0%) 0.00% -0.003 pp 0.00% 0.000 pp USD 9 qtrs SOLD
74 ADVISORY SERVICES NETWORK, LLC -400.0 (-100.0%) -1.3K (-100.0%) 0.00% -0.001 pp 0.00% +0.000 pp USD 2 qtrs SOLD
75 JANE STREET GROUP, LLC -10.3K (-100.0%) -34.0K (-100.0%) 0.00% -0.032 pp 0.00% +0.000 pp USD 2 qtrs SOLD
76 BARCLAYS PLC -9.0 (-100.0%) -30.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
77 CITIGROUP INC -1.0 (-100.0%) -3.0 (-100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 12 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 iShares Micro-Cap ETF IWC 0.02% 328.9K 0.60%
2 Vanguard Extended Market ETF VXF 0.00% 933.9K 0.05%
3 Vanguard U.S. Total Market Shares Index ETF VTS.AX 0.00% 5.4K 0.03%
4 Vanguard U.S. Total Market Index ETF VUN.TO 0.00% 14.7K 0.17%
5 Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO 0.00% 1.1K 0.17%
6 Vanguard Total Stock Market ETF VTI 0.00% 2.52M 0.03%
7 Vanguard All-Equity ETF Portfolio VEQT.TO 0.00% 5.5K 0.22%
8 Vanguard Growth ETF Portfolio VGRO.TO 0.00% 3.0K 0.22%
9 Vanguard Balanced ETF Portfolio VBAL.TO 0.00% 1.2K 0.22%
10 Vanguard Conservative ETF Portfolio VCNS.TO 0.00% 133.63 0.22%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
6
Sells
0
Shares acquired
610.0K
Shares disposed
Cash buys
1.00
Cash sales
Net activity
+610,000
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-01-28 Baskies Arnold M Director P-Purchase A Common Stock 10,000 3.04 30.4K 135,000 D
2026-01-05 Titterton Lewis H jr Director A-Award A Employee Stock Option 25,000 3.18 79.5K 25,000 D
2026-01-05 KUMAR AMIT Director / Officer A-Award A Employee Stock Option 350,000 3.18 1.11M 350,000 D
2026-01-05 Gottschalk Emily Director A-Award A Employee Stock Option 25,000 3.18 79.5K 25,000 D
2026-01-05 Catelani Michael Officer A-Award A Employee Stock Option 175,000 3.18 556.5K 175,000 D
2026-01-05 Baskies Arnold M Director A-Award A Employee Stock Option 25,000 3.18 79.5K 25,000 D
2025-12-15 Titterton Lewis H jr Director M-Exempt A Common Stock 16,000 2.92 46.7K 969,334 D
2025-10-30 KUMAR AMIT Officer F-InKind D Common Stock 169,439 4.06 687.9K 610,486 D
2025-07-31 Titterton Lewis H jr Director P-Purchase A Common Stock 10,000 3.08 30.8K 953,334 D
2025-07-30 KUMAR AMIT Officer P-Purchase A Common Stock 5,000 3.16 15.8K 579,925 D
2025-07-18 Baskies Arnold M Director P-Purchase A Common Stock 5,000 3.39 17.0K 125,000 D
2025-07-11 Titterton Lewis H jr Director P-Purchase A Common Stock 10,000 3.14 31.4K 943,334 D
2025-07-11 KUMAR AMIT Officer P-Purchase A Common Stock 5,000 3.15 15.8K 574,925 D
2025-06-04 KUMAR AMIT Officer P-Purchase A Common Stock 10,000 2.85 28.5K 569,925 D
2025-01-28 Baskies Arnold M Director P-Purchase A Common Stock 5,000 2.82 14.1K 120,000 D
2025-01-24 Titterton Lewis H jr Director P-Purchase A Common Stock 1,000 3.00 3.0K 933,334 D
2025-01-23 Titterton Lewis H jr Director P-Purchase A Common Stock 2,000 2.91 5.8K 932,334 D
2025-01-22 Titterton Lewis H jr Director P-Purchase A Common Stock 2,000 3.01 6.0K 930,334 D
2025-01-21 Titterton Lewis H jr Director P-Purchase A Common Stock 6,000 2.59 15.5K 928,334 D
2025-01-17 Titterton Lewis H jr Director P-Purchase A Common Stock 10,000 2.57 25.7K 922,334 D
2025-01-15 KUMAR AMIT Officer P-Purchase A Common Stock 43,000 2.23 95.9K 559,925 D
2025-01-15 Catelani Michael Officer P-Purchase A Common Stock 9,289 2.15 20.0K 44,500 D
2025-01-02 Titterton Lewis H jr Director A-Award A Employee Stock Option 25,000 2.37 59.3K 25,000 D
2025-01-02 KUMAR AMIT Director / Officer A-Award A Employee Stock Option 700,000 2.37 1.66M 700,000 D
2025-01-02 Gottschalk Emily Director A-Award A Employee Stock Option 25,000 2.37 59.3K 25,000 D
2025-01-02 Catelani Michael Officer A-Award A Employee Stock Option 350,000 2.37 829.5K 350,000 D
2025-01-02 Baskies Arnold M Director A-Award A Employee Stock Option 25,000 2.37 59.3K 25,000 D
2024-10-22 Titterton Lewis H jr Director M-Exempt A Common Stock 16,000 2.58 41.2K 912,334 D
2024-07-31 Titterton Lewis H jr Director P-Purchase A Common Stock 5,580 3.23 18.0K 896,334
2024-07-30 Titterton Lewis H jr Director P-Purchase A Common Stock 21,646 3.06 66.2K 890,754
2024-07-26 Titterton Lewis H jr Director P-Purchase A Common Stock 7,700 3.03 23.3K 869,108
2024-07-26 Baskies Arnold M Director P-Purchase A Common Stock 5,000 3.09 15.5K 115,000
2024-07-25 Titterton Lewis H jr Director P-Purchase A Common Stock 796 2.81 2.2K 861,408
2024-06-14 Titterton Lewis H jr Director P-Purchase A Common Stock 4,000 2.68 10.7K 860,612
2024-06-13 Titterton Lewis H jr Director P-Purchase A Common Stock 405 2.70 1.1K 856,612
2024-06-11 Titterton Lewis H jr Director P-Purchase A Common Stock 7,102 2.66 18.9K 856,207
2024-06-10 Titterton Lewis H jr Director P-Purchase A Common Stock 330 2.60 858.00 849,105
2024-06-07 Titterton Lewis H jr Director P-Purchase A Common Stock 10,738 2.52 27.1K 848,775
2024-06-07 KUMAR AMIT Officer P-Purchase A Common Stock 25,000 2.41 60.3K 516,925
2024-06-07 Catelani Michael Officer P-Purchase A Common Stock 6,250 2.40 15.0K 35,211
2024-04-30 Catelani Michael Officer A-Award A Common Stock 1,189 2.52 3.0K 28,961
2024-04-09 Titterton Lewis H jr Director P-Purchase A Common Stock 15,009 3.28 49.2K 838,037
2024-03-15 KUMAR AMIT Officer P-Purchase A Common Stock 30,000 3.22 96.6K 491,925
2024-03-15 Baskies Arnold M Director P-Purchase A Common Stock 10,000 3.63 36.3K 110,000
2024-01-12 Titterton Lewis H jr Director A-Award A Employee Stock Option (Right to Buy) 25,000 4.39 109.8K 25,000
2024-01-12 KUMAR AMIT Director / Officer A-Award A Employee Stock Option (Right to Buy) 700,000 4.39 3.07M 700,000
2024-01-12 Gottschalk Emily Director A-Award A Employee Stock Option (Right to Buy) 25,000 4.39 109.8K 25,000
2024-01-12 Catelani Michael Officer A-Award A Employee Stock Option (Right to Buy) 350,000 4.39 1.54M 350,000
2024-01-12 Baskies Arnold M Director A-Award A Employee Stock Option (Right to Buy) 25,000 4.39 109.8K 25,000
2023-10-31 Catelani Michael Officer A-Award A Common Stock 1,117 2.69 3.0K 27,772
2023-10-10 Titterton Lewis H jr Director M-Exempt A Common Stock 16,000 2.58 41.2K 823,028
2023-07-31 KUMAR AMIT Director / Officer S-Sale D Common Stock 11,800 3.57 42.1K 461,925
2023-07-28 KUMAR AMIT Director / Officer M-Exempt A Common Stock 40,000 2.58 103.0K 502,100
2023-07-27 Titterton Lewis H jr Director M-Exempt D Employee Stock Option (Right to Buy) 120,000 2.58 309.0K 0
2023-07-20 Catelani Michael Officer P-Purchase A Common Stock 5,500 3.64 20.0K 26,655
2023-04-28 Catelani Michael Officer A-Award A Common Stock 865 3.47 3.0K 21,155
2023-01-03 Titterton Lewis H jr Director A-Award A Employee Stock Option (Right to Buy) 25,000 4.19 104.8K 25,000
2023-01-03 KUMAR AMIT Director / Officer A-Award A Employee Stock Option (Right to Buy) 700,000 4.19 2.93M 700,000
2023-01-03 Gottschalk Emily Director A-Award A Employee Stock Option (Right to Buy) 25,000 4.19 104.8K 25,000
2023-01-03 Catelani Michael Officer A-Award A Employee Stock Option (Right to Buy) 350,000 0.00 350,000
2023-01-03 Baskies Arnold M Director A-Award A Employee Stock Option (Right to Buy) 25,000 0.00 25,000
2022-10-31 Catelani Michael Officer J-Other A Common Stock 1,069 2.81 3.0K 20,290
2022-09-29 Titterton Lewis H jr Director M-Exempt A Common Stock 40,000 2.58 103.0K 774,070
2022-09-15 KUMAR AMIT Director / Officer M-Exempt D Employee Stock Option (Right to Buy) 640,000 2.58 1.65M 0
2022-09-14 Titterton Lewis H jr Director G-Gift D Common Stock 300,000 0.00 734,070
2022-06-24 Titterton Lewis H jr Director M-Exempt A Common Stock 16,000 2.58 41.2K 1,034,070
2022-04-29 Catelani Michael Officer J-Other A Common Stock 1,086 2.76 3.0K 19,221
2022-04-26 Titterton Lewis H jr Director P-Purchase A Common Stock 10,000 2.79 27.9K 988,070
2022-04-21 Catelani Michael Officer P-Purchase A Common Stock 5,500 2.66 14.6K 18,135
2022-04-20 Catelani Michael Officer P-Purchase A Common Stock 2,509 2.53 6.3K 12,635
2022-04-14 Catelani Michael Officer A-Award A Employee Stock Option (Right to Buy) 100,000 0.00 100,000
2022-03-10 Titterton Lewis H jr Director A-Award A Employee Stock Option (Right to Buy) 100,000 0.00 100,000
2022-03-10 KUMAR AMIT Officer A-Award A Employee Stock Option (Right to Buy) 500,000 0.00 500,000
2022-03-10 Gottschalk Emily Director A-Award A Employee Stock Option (Right to Buy) 100,000 0.00 100,000
2022-03-10 Catelani Michael Officer A-Award A Employee Stock Option (Right to Buy) 500,000 2.74 1.37M 500,000
2022-03-10 Baskies Arnold M Director A-Award A Employee Stock Option (Right to Buy) 100,000 0.00 100,000
2022-01-12 Titterton Lewis H jr Director P-Purchase A Common Stock 5,000 3.28 16.4K 978,070
2022-01-11 Titterton Lewis H jr Director P-Purchase A Common Stock 2,000 3.20 6.4K 973,070
2022-01-10 Titterton Lewis H jr Director P-Purchase A Common Stock 6,000 3.08 18.5K 971,070
2022-01-07 Titterton Lewis H jr Director P-Purchase A Common Stock 11,000 3.08 33.9K 965,070
2022-01-07 KUMAR AMIT Director / Officer P-Purchase A Common Stock 20,000 3.00 60.0K 314,000
2021-10-29 Titterton Lewis H jr Director P-Purchase A Common Stock 18,244 4.76 86.8K 954,070
2021-10-29 KUMAR AMIT Director / Officer P-Purchase A Common Stock 2,000 4.77 9.5K 294,000
2021-10-29 Catelani Michael Officer J-Other A Common Stock 743 4.04 3.0K 10,126
2021-07-26 Titterton Lewis H jr Director P-Purchase A Common Stock 30,000 4.21 126.3K 935,826
2021-07-23 KUMAR AMIT Director / Officer P-Purchase A Common Stock 5,000 4.28 21.4K 292,000
2021-07-23 Baskies Arnold M Director P-Purchase A Common Stock 19,000 4.33 82.3K 100,000
2021-07-16 Titterton Lewis H jr Director P-Purchase A Common Stock 10,000 4.07 40.7K 905,826
2021-07-16 KUMAR AMIT Director / Officer P-Purchase A Common Stock 10,000 3.94 39.4K 287,000
2021-07-15 Titterton Lewis H jr Director P-Purchase A Common Stock 2,200 3.65 8.0K 895,826
2021-07-15 Gottschalk Emily Director P-Purchase A Common Stock 20,065 3.96 79.5K 45,665
2021-07-15 Baskies Arnold M Director P-Purchase A Common Stock 20,000 3.90 78.0K 81,000
2021-07-14 Titterton Lewis H jr Director P-Purchase A Common Stock 23,300 3.72 86.7K 893,626
2021-06-01 Titterton Lewis H jr Director A-Award A Employee Stock Option (Right to Buy) 200,000 4.02 804.0K 200,000
2021-06-01 KUMAR AMIT Director / Officer A-Award A Employee Stock Option (Right to Buy) 500,000 4.02 2.01M 500,000
2021-06-01 Gottschalk Emily Director A-Award A Employee Stock Option (Right to Buy) 30,000 4.02 120.6K 30,000
2021-06-01 Catelani Michael Officer A-Award A Employee Stock Option (Right to Buy) 100,000 4.02 402.0K 100,000
2021-06-01 Baskies Arnold M Director A-Award A Employee Stock Option (Right to Buy) 30,000 4.02 120.6K 30,000
2021-05-31 KUMAR AMIT Director / Officer D-Return D Restricted Stock Award 1,500,000 0.00 0
2021-04-30 Catelani Michael Officer J-Other A Common Stock 1,634 1.84 3.0K 9,383
2021-04-23 Gottschalk Emily Director P-Purchase A Common Stock 10,000 4.49 44.9K 25,600
2021-04-20 Baskies Arnold M Director P-Purchase A Common Stock 10,000 3.91 39.1K 61,000
2021-04-19 Titterton Lewis H jr Director P-Purchase A Common Stock 5,000 3.99 20.0K 870,326
2021-03-25 Titterton Lewis H jr Director P-Purchase A Common Stock 45,000 4.84 217.8K 865,326
2021-03-25 KUMAR AMIT Director / Officer P-Purchase A Common Stock 5,000 4.86 24.3K 277,000
2021-03-25 Gottschalk Emily Director P-Purchase A Common Stock 15,600 4.88 76.1K 15,600
2021-03-25 Baskies Arnold M Director P-Purchase A Common Stock 10,000 4.80 48.0K 51,000
2021-02-03 Titterton Lewis H jr Director G-Gift D Common Stock 200,000 0.00 820,326
2021-01-29 KUMAR AMIT Director / Officer P-Purchase A Common Stock 10,000 3.73 37.3K 272,000
2020-12-23 KUMAR AMIT Director / Officer A-Award A Employee Stock Option (Right to Buy) 1,000,000 2.83 2.83M 1,000,000
2020-12-23 Catelani Michael Officer A-Award A Employee Stock Option (Right to Buy) 100,000 2.83 283.0K 100,000
2020-10-31 Catelani Michael Officer J-Other A Common Stock 1,918 1.56 3.0K 7,749
2020-09-11 Titterton Lewis H jr Director P-Purchase A Common Stock 40,000 2.08 83.2K 1,020,326
2020-09-11 KUMAR AMIT Director / Officer P-Purchase A Common Stock 28,000 2.11 59.1K 262,000
2020-08-13 Titterton Lewis H jr Director A-Award A Employee Stock Option (Right to Buy) 30,000 2.68 80.4K 30,000
2020-08-13 MONAHAN JOHN J Director A-Award A Employee Stock Option (Right to Buy) 30,000 2.68 80.4K 30,000
2020-08-13 Gottschalk Emily Director A-Award A Employee Stock Option (Right to Buy) 30,000 2.68 80.4K 30,000
2020-08-13 Cavalier David Director A-Award A Employee Stock Option (Right to Buy) 30,000 2.68 80.4K 30,000
2020-08-13 Baskies Arnold M Director A-Award A Employee Stock Option (Right to Buy) 30,000 2.68 80.4K 30,000
2020-06-16 Titterton Lewis H jr Director P-Purchase A Common Stock 24,500 2.27 55.6K 980,326
2020-06-15 Titterton Lewis H jr Director P-Purchase A Common Stock 31,083 2.27 70.6K 955,826
2020-06-12 KUMAR AMIT Director / Officer P-Purchase A Common Stock 20,000 2.03 40.6K 234,000
2020-04-30 Catelani Michael Officer J-Other A Common Stock 1,867 1.61 3.0K 5,829
2020-03-13 Titterton Lewis H jr Director P-Purchase A Common Stock 5,799 2.12 12.3K 924,743
2020-03-12 KUMAR AMIT Director / Officer P-Purchase A Common Stock 20,000 1.82 36.4K 214,000
2020-03-12 Baskies Arnold M Director P-Purchase A Common Stock 10,000 1.84 18.4K 41,000
2020-03-06 Baskies Arnold M Director P-Purchase A Common Stock 10,000 2.71 27.1K 31,000
2020-01-17 Baskies Arnold M Director P-Purchase A Common Stock 10,000 3.53 35.3K 21,000
2020-01-15 Titterton Lewis H jr Director P-Purchase A Common Stock 5,000 3.32 16.6K 918,944
2020-01-14 Titterton Lewis H jr Director P-Purchase A Common Stock 7,400 3.22 23.8K 913,944
2020-01-14 KUMAR AMIT Director / Officer P-Purchase A Common Stock 20,000 2.99 59.8K 194,000
2019-12-12 KUMAR AMIT Director / Officer A-Award A Employee Stock Option (Right to Buy) 520,000 3.84 2.00M 520,000
2019-12-12 Catelani Michael Officer A-Award A Employee Stock Option (Right to Buy) 100,000 3.84 384.0K 100,000
2019-10-31 Catelani Michael Officer J-Other A Common Stock 912 3.29 3.0K 3,962
2019-10-23 Titterton Lewis H jr Director A-Award A Employee Stock Option 45,000 3.87 174.2K 45,000
2019-10-23 MONAHAN JOHN J Director A-Award A Employee Stock Option (Right to Buy) 45,000 3.87 174.2K 45,000
2019-10-23 Gottschalk Emily Director A-Award A Employee Stock Option (Right to Buy) 45,000 3.87 174.2K 45,000
2019-10-23 Cavalier David Director A-Award A Employee Stock Option (Right to Buy) 45,000 3.87 174.2K 45,000
2019-10-23 Baskies Arnold M Director A-Award A Employee Stock Option (Right to Buy) 45,000 3.87 174.2K 45,000
2019-09-20 Titterton Lewis H jr Director A-Award A Employee Stock Option 30,000 2.58 77.3K 30,000
2019-09-20 MONAHAN JOHN J Director D-Return D Employee Stock Option 12,000 0.67 8.0K 0
2019-09-20 KUMAR AMIT Director / Officer A-Award A Employee Stock Option 213,333 2.58 549.3K 213,333
2019-09-20 Catelani Michael Director / Officer A-Award A Employee Stock Option 200,000 0.96 192.0K 200,000
2019-09-20 Baskies Arnold M Director A-Award A Employee Stock Option 12,000 5.30 63.6K 12,000
2019-09-13 Titterton Lewis H jr Director P-Purchase A Common Stock 15,000 4.10 61.5K 906,544
2019-09-13 KUMAR AMIT Director / Officer P-Purchase A Common Stock 10,000 4.12 41.2K 174,000
2019-04-30 Catelani Michael Officer J-Other A Common Stock 800 3.43 2.7K 3,050
2019-04-29 MONAHAN JOHN J Director P-Purchase A Common Stock 900 4.22 3.8K 50,900
2019-04-29 Cavalier David Director P-Purchase A Common Stock 2,000 4.21 8.4K 2,000
2019-04-26 KUMAR AMIT Director / Officer P-Purchase A Common Stock 4,000 4.21 16.8K 164,000
2019-04-26 Baskies Arnold M Director P-Purchase A Common Stock 10,000 4.28 42.8K 11,000
2019-04-24 KUMAR AMIT Director / Officer P-Purchase A Common Stock 10,000 4.27 42.7K 160,000
2019-04-22 Titterton Lewis H jr Director P-Purchase A Common Stock 50,000 4.09 204.5K 891,544
2018-10-25 Titterton Lewis H jr Director P-Purchase A Common Stock 2,000 4.05 8.1K 841,544
2018-10-25 KUMAR AMIT Director / Officer P-Purchase A Common Stock 11,000 3.90 42.9K 150,000
2018-10-08 MONAHAN JOHN J Director A-Award A Employee Stock Option (Right to Buy) 45,000 5.29 238.1K 45,000
2018-10-08 Cavalier David Director A-Award A Employee Stock Option (Right to Buy) 45,000 5.29 238.1K 45,000
2018-10-08 Baskies Arnold M Director A-Award A Employee Stock Option (Right to Buy) 45,000 5.29 238.1K 45,000
2018-09-27 Cavalier David Director D Common Stock 0 0.00 0
2018-09-27 Baskies Arnold M Director D Common Stock 0 0.00 1,000
2018-09-18 Catelani Michael Officer P-Purchase A Common Stock 2,250 4.45 10.0K 2,250
2018-09-14 Titterton Lewis H jr Director P-Purchase A Common Stock 5,000 3.98 19.9K 839,544
2018-09-14 KUMAR AMIT Director / Officer P-Purchase A Common Stock 3,000 4.08 12.2K 139,000
2018-09-13 KUMAR AMIT Director / Officer P-Purchase A Common Stock 3,000 3.84 11.5K 136,000
2018-09-12 KUMAR AMIT Director / Officer P-Purchase A Common Stock 4,480 3.99 17.9K 128,888
2018-07-26 Titterton Lewis H jr Director A-Award A Employee Stock Option 300,000 3.46 1.04M 300,000
2018-05-08 KUMAR AMIT Director / Officer A-Award A Restricted Stock Award 1,500,000 0.00 1,500,000
2018-05-08 Catelani Michael Officer A-Award A Employee Stock Option 500,000 3.70 1.85M 500,000
2018-04-09 WILLIAMS RICHARD H Director S-Sale D Common Stock 25,000 4.64 116.0K 25,000
2017-10-19 Titterton Lewis H jr Director M-Exempt A Common Stock 2,400 0.67 1.6K 834,544
2017-09-22 WILLIAMS RICHARD H Director A-Award A Employee Stock Options (right to Buy) 50,000 2.27 113.5K 50,000
2017-09-22 Titterton Lewis H jr Director A-Award A Employee Stock Options (Right to Buy) 50,000 2.27 113.5K 50,000
2017-09-22 MONAHAN JOHN J Director A-Award A Employee Stock Options (Right to Buy) 50,000 2.27 113.5K 50,000
2017-09-22 JOHNSON BRUCE F Director A-Award A Employee Stock Options (Right to Buy) 50,000 2.27 113.5K 50,000
2017-09-06 Titterton Lewis H jr Director A-Award A Employee Stock Option 16,000 0.67 10.7K 16,000
2017-09-06 MONAHAN JOHN J Director D-Return D Employee Stock Option 6,000 3.13 18.8K 0
2017-09-06 KUMAR AMIT Director / Officer A-Award A Employee Stock Option 320,000 0.67 214.4K 320,000
2017-09-06 Fox Dale Director A-Award A Employee Stock Option 12,000 0.67 8.0K 12,000
2017-09-06 Catelani Michael Officer A-Award A Employee Stock Option 200,000 0.67 134.0K 200,000
2017-09-06 Baskies Arnold M Director D-Return D Employee Stock Option 6,000 3.13 18.8K 0
2017-07-17 Titterton Lewis H jr Director D Employee Stock Options (Right to Buy) 6,000 0.82 4.9K 0
2017-07-06 Catelani Michael Officer A-Award A Employee Stock Option (Right to Buy) 200,000 0.96 192.0K 200,000
2017-06-05 KUMAR AMIT Director P-Purchase A Common Stock 10,000 0.90 9.0K 124,408
2017-06-02 KUMAR AMIT Director P-Purchase A Common Stock 8,078 0.88 7.1K 114,408
2017-06-02 BERMAN ROBERT ANDREW Director / Officer P-Purchase A Common Stock 9,900 0.88 8.7K 61,553
2017-04-03 BERMAN ROBERT ANDREW Officer X-InTheMoney D Subscription Right 5,995 2.38 14.3K 0
2017-01-03 MONAHAN JOHN J Director A-Award A Employee Stock Options (Right to Buy) 12,000 5.30 63.6K 12,000
2017-01-03 Fox Dale Director A-Award A Employee Stock Option (Right to Buy) 12,000 5.30 63.6K 12,000
2017-01-03 Baskies Arnold M Director A-Award A Employee Stock Option (Right to Buy) 12,000 5.30 63.6K 12,000
2016-12-31 Titterton Lewis H jr Director D Employee Stock Options (Right to Buy) 16,000 2.92 46.7K 0
2016-12-31 JOHNSON BRUCE F Director D Employee Stock Options (Right to Buy) 12,000 2.92 35.0K 0
2016-11-15 Catelani Michael Officer A-Award A Employee Stock Option (Right to Buy) 50,000 4.85 242.5K 50,000
2016-11-01 Catelani Michael Officer D Common Stock 0 0.00 0
2016-10-20 HERMS HENRY P Officer M-Exempt D Employee Stock Option 2,000 2.58 5.2K 0
2016-08-24 Titterton Lewis H jr Director S-Sale D Common Stock 210,000 3.10 651.0K 287,437
2016-08-23 MONAHAN JOHN J Director D Employee Stock Option 6,000 3.13 18.8K 0
2016-08-23 Baskies Arnold M Director D Common Stock 0 0.00 0
2016-06-30 JOHNSON BRUCE F Director P-Purchase A Common Stock 4,500 3.26 14.7K 419,119
2016-06-27 JOHNSON BRUCE F Director P-Purchase A Common Stock 400 3.16 1.3K 414,619
2016-06-17 JOHNSON BRUCE F Director P-Purchase A Common Stock 200 3.34 668.00 414,219

Executive team

Top executives
Shares Outstanding
33.53M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Dr. Amit Kumar Chairman of the Board and Chief Executive Officer 815.2K 500.0K 1.13M 102.4K 2.55M 44.34%
2 2025 Michael J. Catelani President, Chief Operating Officer and Chief Financial Officer 553.2K 150.0K 564.6K 31.0K 1.30M 43.47%
3 2024 Dr. Amit Kumar Chairman of the Board and Chief Executive Officer 785.5K 500.0K 2.09M 97.6K 3.48M 60.21%
4 2024 Michael J. Catelani President, Chief Operating Officer and Chief Financial Officer 533.0K 150.0K 1.05M 30.5K 1.76M 59.46%
5 2023 Dr. Amit Kumar Chairman of the Board and Chief Executive Officer 720.3K 500.0K 2.35M 65.2K 3.64M 64.68%
6 2023 Michael J. Catelani President, Chief Operating Officer and Chief Financial Officer 488.8K 300.0K 1.18M 1.97M 59.87%
7 2022 Dr. Amit Kumar Chairman of the Board and Chief Executive Officer 630.6K 400.0K 1.09M 40.4K 2.16M 50.39%
8 2022 Michael J. Catelani President, Chief Operating Officer and Chief Financial Officer 401.0K 150.0K 1.30M 1.85M 70.20%
9 2021 Dr. Amit Kumar Chairman of the Board and Chief Executive Officer 573.3K 200.0K 10.15M 39.2K 10.96M 92.59%
10 2021 Dr. Amit Kumar Chairman of the Board, President and Chief Executive Officer 573.3K 200.0K 10.15M 39.2K 10.96M 92.59%
11 2021 Michael J. Catelani Chief Operating Officer and Chief Financial Officer 315.7K 100.0K 866.7K 1.28M 67.58%
12 2021 Michael J. Catelani President, Chief Operating Officer and Chief Financial Officer 315.7K 100.0K 866.7K 1.28M 67.58%
13 2020 Dr. Amit Kumar Chairman of the Board, President and Chief Executive Officer 521.6K 160.0K 1.67M 39.2K 2.40M 69.90%
14 2020 Michael J. Catelani Chief Operating Officer and Chief Financial Officer 287.2K 50.0K 322.0K 659.2K 48.85%
15 2019 Dr. Amit Kumar Chairman of the Board, President and Chief Executive Officer 476.3K 150.0K 39.2K 665.5K 0.00%
16 2019 Michael J. Catelani Chief Operating Officer and Chief Financial Officer 263.0K 50.0K 313.0K 0.00%
17 2016 Robert A. Berman Chief Executive Officer and Director 300.0K 200.0K 566.9K 12.0K 1.08M 52.54%
18 2016 Dr. Amit Kumar Executive Chairman of the Board 300.0K 200.0K 566.9K 12.0K 1.08M 52.54%
19 2016 Dr. Amit Kumar Chairman of the Board, President and Chief Executive Officer 300.0K 141.9K 12.0K 453.9K 31.27%
20 2016 Henry P. Herms Chief Financial Officer, Vice President- Finance 87.5K 85.0K 172.5K 49.29%
21 2015 Robert A. Berman President, Chief Executive Officer and Director 300.0K 150.0K 169.1K 4.2K 623.2K 27.13%
22 2015 Robert A. Berman Chief Executive Officer and Director 300.0K 150.0K 169.1K 4.2K 623.2K 27.13%
23 2015 Dr. Amit Kumar Vice Chairman of the Board, Executive Chairman and Chief Executive Officer of Anixa Diagnostics 189.0K 150.0K 169.1K 508.1K 33.28%
24 2015 Henry P. Herms Chief Financial Officer, Vice President- Finance 168.0K 16.3K 184.3K 8.82%
25 2015 Henry P. Herms Chief Financial Officer and Vice President- Finance 168.0K 184.3K 0.00%
26 2015 Dr. Amit Kumar Executive Chairman of the Board 112.5K 112.5K 0.00%
27 2014 Henry P. Herms Chief Financial Officer, Vice President- Finance Director 850.2K 928.8K 91.53%
28 2014 Robert A. Berman President, Chief Executive Officer and Director 300.0K 200.0K 254.5K 8.3K 762.8K 33.36%
29 2014 Robert A. Berman Chief Executive Officer and Director 300.0K 200.0K 500.0K 0.00%
30 2014 Tisha Stender Chief Operating Officer and Legal Counsel 32.2K 340.0K 0.00%
31 2014 Henry P. Herms Chief Financial Officer and Vice President- Finance 168.0K 16.3K 260.5K 6.24%
32 2013 Robert A. Berman Chief Executive Officer and Director 290.0K 254.5K 8.3K 762.8K 33.36%
33 2013 John Roop Senior Vice President of Engineering 225.0K 69.2K 234.3K 29.55%
34 2013 Henry P. Herms Chief Financial Officer, Vice President- Finance Director 168.0K 168.0K 0.00%
35 2013 Henry P. Herms Chief Financial Officer, Vice President- Finance and Director 150.0K 150.0K 0.00%
36 2012 Robert A. Berman President, Chief Executive Officer and Director 32.2K 2.88M 2.91M 98.89%
37 2012 Denis A. Krusos , Director and Former Chairman of the Board and Chief Executive Officer 208.3K 29.1K 237.5K 0.00%
38 2012 Henry P. Herms Chief Financial Officer, Vice President- Finance and Director 150.0K 166.7K 0.00%
39 2012 Henry P. Herms Chief Financial Officer, Vice President- Finance Director 150.0K 150.0K 0.00%
40 2012 Lewis H. Titterton, Jr. Interim Chief Executive Officer and Chairman of the Board 136.6K 136.6K 100.00%
41 2012 Robert A. Berman Chief Executive Officer and Director 50.0K 50.0K 0.00%
42 2012 John Roop Senior Vice President of Engineering 15.0K 15.0K 0.00%
43 2011 Denis A. Krusos , Director and Former Chairman of the Board and Chief Executive Officer 250.0K 34.8K 664.2K 0.00%
44 2011 Henry P. Herms Chief Financial Officer, Vice President- Finance and Director 129.2K 16.7K 145.8K 0.00%
45 2010 Denis A. Krusos , Director and Former Chairman of the Board and Chief Executive Officer 250.0K 200.0K 179.4K 37.5K 287.5K 62.38%
46 2010 Denis A. Krusos, Chairman of the Board, Chief Executive Officer and Director 250.0K 37.5K 287.5K 0.00%
47 2010 Henry P. Herms Chief Financial Officer, Vice President- Finance and Director 125.0K 69.2K 16.2K 153.7K 45.02%
48 2009 Denis A. Krusos, Chairman of the Board, Chief Executive Officer and Director 250.0K 748.5K 39.8K 1.04M 72.09%
49 2009 Denis A. Krusos , Director and Former Chairman of the Board and Chief Executive Officer 250.0K 748.5K 39.8K 1.04M 72.09%
50 2009 Henry P. Herms Chief Financial Officer, Vice President- Finance and Director 125.0K 74.9K 18.8K 218.6K 34.24%
51 2008 Denis A. Krusos, Chairman of the Board, Chief Executive Officer and Director 250.0K 967.0K 33.9K 1.25M 77.30%
52 2008 Henry P. Herms Chief Financial Officer, Vice President- Finance and Director 125.0K 72.5K 21.8K 219.3K 33.07%
53 2008 Frank J. DiSanto Former President and former Director 42.0K 117.2K 10.0K 169.1K 69.28%
54 2007 Denis A. Krusos, Chairman of the Board, Chief Executive Officer and Director 250.0K 422.2K 28.5K 700.7K 60.25%
55 2007 Henry P. Herms Chief Financial Officer, Vice President- Finance and Director 100.0K 30.2K 14.3K 144.5K 20.88%
56 2007 Henry P. Herms Chief Financial Officer, Vice President – Finance and Director 100.0K 30.2K 14.3K 144.5K 20.88%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-01-28 DEF 14A
2025-02-06 DEF 14A
2024-02-08 DEF 14A
2023-01-27 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-03-11 8-K
2026-03-09 10-Q
2026-02-09 8-K
2026-01-29 4
2026-01-28 DEF 14A
2026-01-12 S-8
2026-01-12 10-K
2026-01-06 SC 13D/A
2026-01-06 4
2026-01-06 4

Executive team

NameTitleCompensationGender
Amit Kumar Chief Executive Officer, Chairman & Co-Chair of CBAB 1M
Michael J. Catelani President, Chief Operating Officer, Chief Financial Officer & Corporate Secretary 734.2K male
Pamela D. Garzone Chief Development Officer & Chair Breast Cancer Clinical Advisory Board
ESG Rating
B-
BIOTECHNOLOGY
Rank: 677 out of 714
2008
E (Environmental)
64.0 / 56.3
Company / Sector avg.
S (Social)
67.4 / 62.4
Company / Sector avg.
G (Governance)
66.6 / 60.9
Company / Sector avg.
ESG Total
66.0 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits